| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Garcia Vicién, Gemma |
| dc.contributor.author | Ruiz, Nuria |
| dc.contributor.author | Ruffinelli, Jose Carlos |
| dc.contributor.author | Mils, Kristel |
| dc.contributor.author | Bañuls, María |
| dc.contributor.author | Micke, Patrick |
| dc.contributor.author | Mezheyeuski, Artur |
| dc.date.accessioned | 2025-01-10T13:35:39Z |
| dc.date.available | 2025-01-10T13:35:39Z |
| dc.date.issued | 2024-12-04 |
| dc.identifier.citation | Garcia-Vicién G, Ruiz N, Micke P, Ruffinelli JC, Mils K, Bañuls M, et al. The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells. MedComm. 2024 Dec;5(12):e70000. |
| dc.identifier.issn | 2688-2663 |
| dc.identifier.uri | https://hdl.handle.net/11351/12395 |
| dc.description | Desmoplàsia; Metàstasis hepàtiques; Patró de creixement histològic |
| dc.description.sponsorship | This work has been supported by grant PI18/1140 from the Fondo de Investigaciones Sanitarias of the Spanish Government (grantPI18/1140), Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa”/“A way of shaping Europe” and AGAUR grant number SGR771 and 2019FI_B00673. A. M. was supported by grant from the Swedish Cancer Society to (CAN 2017/1066), Selanders Foundation and P.O. Zetterling Foundation. In addition, G. G. V. is recipient of the 2019 FI_B 00673 grant, funded by AGAUR the Department of Health of the Generalitat de Catalunya by the call “Ajuts per a la contractació de personal investigador novell FI 2019.” We thank CERCA Programme/Generalitat de Catalunya for institutional support. |
| dc.language.iso | eng |
| dc.publisher | Wiley |
| dc.relation.ispartofseries | MedComm;5(12) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Prognosi |
| dc.subject | Metàstasi |
| dc.subject | Còlon - Càncer |
| dc.subject | Recte - Càncer |
| dc.subject | Fetge - Càncer |
| dc.subject.mesh | Neoplasm Metastasis |
| dc.subject.mesh | Colorectal Neoplasms |
| dc.subject.mesh | Tumor Microenvironment |
| dc.subject.mesh | Liver Neoplasms |
| dc.subject.mesh | Prognosis |
| dc.title | The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1002/mco2.70000 |
| dc.subject.decs | metástasis neoplásica |
| dc.subject.decs | neoplasias colorrectales |
| dc.subject.decs | microambiente tumoral |
| dc.subject.decs | neoplasias hepáticas |
| dc.subject.decs | pronóstico |
| dc.relation.publishversion | https://doi.org/10.1002/mco2.70000 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Garcia-Vicién G] Tumoural and Stromal Chemoresistance Group, Oncobell Program, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain. [Ruiz N] Tumoural and Stromal Chemoresistance Group, Oncobell Program, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain. Department of Pathology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain. [Micke P] Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. [Ruffinelli JC] Tumoural and Stromal Chemoresistance Group, Oncobell Program, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain. Department of Medical Oncology, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain. [Mils K] Tumoural and Stromal Chemoresistance Group, Oncobell Program, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain. Department of Surgery, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain. [Bañuls M] Program Against Cancer Therapeutic Resistance (ProCURE), Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain. [Mezheyeuski A] Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| dc.identifier.pmid | 39563958 |
| dc.identifier.wos | 001369933000001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |